CD44 and neoplasm: Furthermore, the combination treatment significantly increased the central memory phenotype of CD8+ T cells (TCM, CD44+ CD62L+; p < 0.01) in the spleens of tumor-bearing mice (Fig. 7d, e; Supplementary Fig. 6c).